Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance (PROVE)
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
This study is designed to prospectively collect blood samples and clinical data from patients that have been newly diagnosed with colorectal cancer and scheduled for resection surgery but are pre cancer treatment, subjects who are NOT scheduled for surgery but have histological confirmation of CRC from the diagnostic colonoscopy and clinical staging (cTMN) is available and are pr e- treatment, and patients who are at average risk of colorectal cancer and who are scheduled for routine colonoscopy examinations.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 45
Maximum Age: 84
Healthy Volunteers: t
View:
• Arm A: Diagnosed with CRC
• Arm B: Undergoing screening with colonoscopy for CRC
Locations
United States
Illinois
Gastroenterology and Internal Medicine Specialists
RECRUITING
Lake Barrington
Contact Information
Primary
Antonio Jesus Merino Calvo
antonio.merino@universaldx.com
674945571
Time Frame
Start Date: 2023-07-31
Estimated Completion Date: 2027-07
Participants
Target number of participants: 6500
Treatments
Arm A
Patients newly diagnosed with CRC who have not yet had treatment or surgery.
Arm B
People at average risk of CRC undergoing screening for colorectal cancer with colonoscopy.
Related Therapeutic Areas
Sponsors
Leads: Universal Diagnostics